Clinical Trial RESULTS
Clinical Trial
RESULTS
Research Sponsor: AstraZeneca AB
Drug Studied: AZD9977
National Clinical Trial #: NCT02484729
Eudra CT #: 2015-000877-11
Protocol #: D6400C00001
Study Date: July 2015 to November 2015
Short Study Title: A study in healthy males to investigate a new drug
for the potential treatment of chronic kidney disease
Thank you!
As a clinical study participant, you belong to a large community of participants
around the world. You help researchers answer important health questions
and discover new medical treatments.
Thank you for taking part in the clinical study for the study drug AZD9977.
AZD9977 is a new drug being developed to treat kidney disease, including
kidney disease from diabetes. You and all of the participants helped
researchers learn how AZD9977 affects the body.
Astra Zeneca AB, the sponsor of this study, thanks you for your help and
thinks it is important for you to know the results of your study. An
independent non-profit organization called CISCRP and a medical writing
organization called Synchrogenix prepared this summary of the study results
for you. We hope it helps you understand and feel proud of your important
role in medical research. If you have questions about the results, please speak
with the doctor or staff at your study site.
11